PTC
BIVI icon

Philadelphia Trust Company’s BioVie BIVI Stock Holding History

Philadelphia Trust Company’s Portfolio BIVI Stock Details BIVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$105K Hold
75,010
– – 0.01% 259
2025
Q4 		$87K Hold
75,010
– – 0.01% 252
2025
Q3 		$143K Buy
+75,010
New +$304K 0.01% 249

Other funds holding BIVI

DC
Diametric Capital Boston, Massachusetts $385M AUM 31.69% 1-Year Est. Return
PCM
Prelude Capital Management New York $1.31B AUM 62.01% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Philadelphia Trust Company's BIVI Position: Q1 2026 in Review

Philadelphia Trust Company held its BioVie (BIVI) position steady in Q1 2026 at 75,010 shares worth $105K. The position accounts for 0.01% of the portfolio, ranked #259.

Philadelphia Trust Company first reported a position in BIVI in Q3 2025 and has held it in 3 quarters since. The position peaked at $143K in Q3 2025. 33 funds tracked by Wall St. Rank hold BIVI as of Q1 2026.

  • Philadelphia Trust Company held 75,010 shares of BioVie worth $105K as of Q1 2026.
  • Philadelphia Trust Company left its BioVie share count unchanged in Q1 2026.
  • BioVie made up 0.01% of Philadelphia Trust Company's portfolio in Q1 2026, its #259 holding.
  • Philadelphia Trust Company first reported a position in BioVie in Q3 2025 and has held it in 3 quarters since.
  • Philadelphia Trust Company's BioVie position peaked at $143K in Q3 2025.
  • 33 funds tracked by Wall St. Rank held BioVie as of Q1 2026.

Based on Philadelphia Trust Company's 13F filing for Q1 2026, filed 13 May 2026.